301126 达嘉维康
已收盘 12-20 15:00:00
资讯
新帖
简况
达嘉维康（301126）12月18日主力资金净卖出526.94万元
证券之星 · 12-19 09:25
达嘉维康（301126）12月18日主力资金净卖出526.94万元
破发股达嘉维康8187万股解禁 2021年上市募6.4亿
中国经济网 · 12-09
破发股达嘉维康8187万股解禁 2021年上市募6.4亿
达嘉维康（301126）2926.21万股限售股将于12月9日解禁，占总股本14.25%
证券之星 · 12-09
达嘉维康（301126）2926.21万股限售股将于12月9日解禁，占总股本14.25%
12月6日达嘉维康发布公告，其股东减持173.91万股
证券之星 · 12-06
12月6日达嘉维康发布公告，其股东减持173.91万股
达嘉维康(301126.SZ)特定股东量吉投资及其一致行动人完成减持173.91万股
智通财经 · 12-06
达嘉维康(301126.SZ)特定股东量吉投资及其一致行动人完成减持173.91万股
达嘉维康：81870219股限售股将于12月9日上市流通
证券 · 12-05
达嘉维康：81870219股限售股将于12月9日上市流通
达嘉维康(301126.SZ)8187.02万股限售股将于12月9日上市流通
智通财经 · 12-05
达嘉维康(301126.SZ)8187.02万股限售股将于12月9日上市流通
达嘉维康:解禁股即将上市，公司回应股价破发，股东人数达15,721人
问董秘 · 12-03
达嘉维康:解禁股即将上市，公司回应股价破发，股东人数达15,721人
达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%
证券之星 · 11-04
达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%
达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 10-31
达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
证券之星 · 10-30
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
证券之星 · 10-10
达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%
达嘉维康(301126.SZ)：设立全资子公司再生医学研究院
智通财经 · 09-27
达嘉维康(301126.SZ)：设立全资子公司再生医学研究院
达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区
证券之星 · 09-10
达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区
商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。
美港电讯 · 09-09
商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。
A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。
美港电讯 · 09-05
A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。
达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司
证券之星 · 09-03
达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司
联邦制药与达嘉维康举行合作交流座谈会
联邦制药 · 09-03
联邦制药与达嘉维康举行合作交流座谈会
达嘉维康最新公告：股东拟减持不超过3%
证券之星 · 09-02
达嘉维康最新公告：股东拟减持不超过3%
达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份
智通财经 · 09-02
达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份
暂无数据
公司概况
公司名称：
湖南达嘉维康医药产业股份有限公司
所属行业：
批发业
上市日期：
2021-12-07
主营业务：
湖南达嘉维康医药产业股份有限公司主要从事药品、生物制品、医疗器械等产品的分销及零售业务。公司主要服务包括分销业务、“特门服务”药房业务、DTP业务、生殖医院业务以及药房传统业务。公司凭借专业药房的规范化管理，2019年通过《零售药店经营特殊疾病药品服务规范》（“特药药房标准”），成为全国第一批达标药店，并荣获“2019年度十大DTP药房”、“2019年中国药品零售最具竞争力优秀门店”、“2019年度全国百家优秀民营医药商业流通企业”、“2020年优秀DTP专业药房”。
发行价格：
12.37
{"stockData":{"symbol":"301126","market":"SZ","secType":"STK","nameCN":"达嘉维康","latestPrice":11.29,"timestamp":1734678231000,"preClose":11.08,"halted":0,"volume":3528343,"delay":0,"floatShares":138000000,"shares":204999999,"eps":0.2285,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"12-20 15:00:00","open":11.1,"high":11.3,"low":11.07,"amount":39571200,"amplitude":0.0208,"askPrice":11.29,"askSize":8,"bidPrice":11.27,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.2285,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":11.08,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":12.19,"lowLimit":9.97,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":205403200,"pbRate":1.29,"roa":"--","roe":"2.06%","epsLYR":0.17,"committee":-0.276054,"marketValue":2319000000,"floatMarketCap":1557000000,"peRate":49.409192,"changeRate":0.019,"turnoverRate":0.0256,"status":0},"requestUrl":"/m/hq/s/301126/tweets","defaultTab":"tweets","newsList":[{"id":"2492193068","title":"达嘉维康（301126）12月18日主力资金净卖出526.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492193068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492193068?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:25","pubTimestamp":1734571520,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月18日收盘，达嘉维康报收于11.19元，下跌1.76%，换手率3.43%，成交量4.73万手，成交额5331.61万元。近5日资金流向一览见下表：达嘉维康融资融券信息显示，融资方面，当日融资买入506.7万元，融资偿还562.66万元，融资净偿还55.95万元。达嘉维康主营业务：主要从事药品、生物制品、医疗器械等产品的分销及零售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900008938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2490879911","title":"破发股达嘉维康8187万股解禁 2021年上市募6.4亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879911","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879911?lang=zh_cn&edition=full","pubTime":"2024-12-09 11:24","pubTimestamp":1733714640,"startTime":"0","endTime":"0","summary":"本次解除限售股份上市流通日为2024年12月9日。 达嘉维康2021年12月7日在深交所创业板上市，公开发行股票5162.6425万股，发行价格为12.37元/股。达嘉维康于2021年12月2日披露的招股说明书显示，公司拟募集资金5.10亿元，分别用于连锁药房拓展项目、智能物流中心项目、偿还银行贷款。发行费用总额为6914.90万元，其中保荐机构国金证券股份有限公司获得保荐承销费用4716.98万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-09/doc-incyvtfx2760157.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-09/doc-incyvtfx2760157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2490561769","title":"达嘉维康（301126）2926.21万股限售股将于12月9日解禁，占总股本14.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490561769","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490561769?lang=zh_cn&edition=full","pubTime":"2024-12-09 08:02","pubTimestamp":1733702556,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，达嘉维康于12月9日将有2926.21万股限售股份解禁，为公司首发原股东限售股份，占公司总股本14.25%。本次解禁后，公司还有6751.99万股限售股份，占总股本32.87%。达嘉维康主营业务：主要从事药品、生物制品、医疗器械等产品的分销及零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900001186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2489328916","title":"12月6日达嘉维康发布公告，其股东减持173.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489328916","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489328916?lang=zh_cn&edition=full","pubTime":"2024-12-06 20:01","pubTimestamp":1733486474,"startTime":"0","endTime":"0","summary":"证券之星消息，12月6日达嘉维康发布公告《达嘉维康:关于特定股东减持计划时间届满的公告》，其股东宁波梅山保税港区量吉股权投资合伙企业(有限合伙)、宁波梅山保税港区淳康股权投资合伙企业(有限合伙)于2024年9月30日至2024年11月12日间合计减持173.91万股，占公司目前总股本的0.8467%，变动期间该股股价上涨26.43%，截止11月12日收盘报12.58元。股东增减持详情见下表：根据达嘉维康2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600040030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2489288902","title":"达嘉维康(301126.SZ)特定股东量吉投资及其一致行动人完成减持173.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489288902","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489288902?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:13","pubTimestamp":1733483628,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，截至2024年12月5日，公司特定股东宁波梅山保税港区量吉股权投资合伙企业(有限合伙)(简称“量吉投资”)及其一致行动人宁波梅山保税港区淳康股权投资合伙企业(有限合伙)(简称“淳康投资”)合计减持公司股份173.91万股，占总股本比例0.85%，本次减持计划时间已届满。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2489917432","title":"达嘉维康：81870219股限售股将于12月9日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2489917432","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489917432?lang=zh_cn&edition=full","pubTime":"2024-12-05 19:05","pubTimestamp":1733396700,"startTime":"0","endTime":"0","summary":"证券日报网讯12月5日晚间，达嘉维康发布首次公开发行前已发行股份上市流通提示性公告称，本次解除限售的股份为公司首次公开发行前已发行的部分股份，本次解除限售股东户数共计5户，解除限售股份数量为81，870，219股，占公司总股本的39.86%。本次解除限售股份上市流通日期为2024年12月9日（星期一）。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-05/doc-incymitn9635869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2489484808","title":"达嘉维康(301126.SZ)8187.02万股限售股将于12月9日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2489484808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489484808?lang=zh_cn&edition=full","pubTime":"2024-12-05 16:38","pubTimestamp":1733387882,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，公司本次解除限售股东户数共计5户，解除限售股份数量为8187.02万股，占公司总股本的39.86%，上市流通日为2024年12月9日(星期一)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2488150993","title":"达嘉维康:解禁股即将上市，公司回应股价破发，股东人数达15,721人","url":"https://stock-news.laohu8.com/highlight/detail?id=2488150993","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488150993?lang=zh_cn&edition=full","pubTime":"2024-12-03 16:45","pubTimestamp":1733215500,"startTime":"0","endTime":"0","summary":"投资者提问：公司解禁股马上要上市了，股价还处在破发状态，公司有没有什么应对措施，大股东和董监高能不能出承诺函，股价不低于多少不减持，现在股东人数有多少？董秘回答(达嘉维康SZ301126)：您好，二级市场股票价格受国内外经济形势、行业等多重因素影响，公司将持续做好经营管理，努力提升业绩，不断增强核心竞争力，推动公司高质量发展，积极回馈股东。截止2024年11月29日，公司股东人数为15,721人。感谢您的关注！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-12-03/doc-incyerfr4786567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2480713453","title":"达嘉维康(301126)10月31日股东户数1.56万户，较上期减少0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480713453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480713453?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:07","pubTimestamp":1730711224,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年10月31日公司股东户数为1.56万户，较9月30日减少89.0户，减幅为0.57%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至10月31日，医药商业行业平均股东户数为3.96万户。从股价来看，2024年9月30日至2024年10月31日，达嘉维康区间涨幅为2.95%，在此期间股东户数减少89.0户，减幅为0.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400022563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2479798114","title":"达嘉维康（301126）2024年三季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2479798114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479798114?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:46","pubTimestamp":1730328362,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期达嘉维康发布2024年三季报。截至本报告期末，公司营业总收入39.83亿元，同比上升43.43%，归母净利润3645.04万元，同比上升53.04%。本报告期达嘉维康三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达39.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126"],"gpt_icon":0},{"id":"2479278923","title":"达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479278923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479278923?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:29","pubTimestamp":1730280574,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年9月30日公司股东户数为1.57万户，较8月9日减少872.0户，减幅为5.26%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.96万户。从股价来看，2024年8月9日至2024年9月30日，达嘉维康区间涨幅为16.3%，在此期间股东户数减少872.0户，减幅为5.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000033813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2474979156","title":"达嘉维康(301126)9月30日股东户数1.57万户，较上期减少5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474979156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474979156?lang=zh_cn&edition=full","pubTime":"2024-10-10 17:01","pubTimestamp":1728550896,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达嘉维康披露，截至2024年9月30日公司股东户数为1.57万户，较8月9日减少872.0户，减幅为5.26%。在医药商业行业个股中，达嘉维康股东户数低于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.78万户。从股价来看，2024年8月9日至2024年9月30日，达嘉维康区间涨幅为16.3%，在此期间股东户数减少872.0户，减幅为5.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101000030146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2470775237","title":"达嘉维康(301126.SZ)：设立全资子公司再生医学研究院","url":"https://stock-news.laohu8.com/highlight/detail?id=2470775237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470775237?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:24","pubTimestamp":1727425458,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，公司以自有资金出资1000万元人民币设立全资子公司湖南达嘉维康再生医学研究院有限公司(“达嘉维康再生医学研究院”)。近日，达嘉维康再生医学研究院已完成工商注册登记，并取得了长沙县市场监督管理局下发的《营业执照》。据悉，本次设立全资子公司有利于进一步加强公司在医疗服务领域的发展力度，提升公司在该领域的基础研究和应用研究能力，实现公司在该领域的技术储备，相关研究成果转化。这一战略布局有望高效联动公司旗下子公司(长沙嘉辰生殖与遗传专科医院有限公司)的医疗服务板块，有助于公司更好地把握医疗健康产业的发展机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2466574435","title":"达嘉维康：公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区","url":"https://stock-news.laohu8.com/highlight/detail?id=2466574435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466574435?lang=zh_cn&edition=full","pubTime":"2024-09-10 19:01","pubTimestamp":1725966090,"startTime":"0","endTime":"0","summary":"证券之星消息，达嘉维康(301126)09月10日在投资者关系平台上答复投资者关心的问题。投资者：达嘉维康海南分公司有位于这次药品进口免税区吗？达嘉维康董秘：您好，公司子公司海南达嘉维康鸿春堂药房连锁有限公司门店主要分布于海口市龙华区、美兰区、琼山区。公司将持续关注市场需求和行业发展趋势，依据市场动态和公司战略规划，审慎考虑未来在药品进口免税区布局的可能性，以期更好地把握市场机遇，提升公司的市场竞争力和服务水平。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000030766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2466900911","title":"商业连锁板块震荡走强，上海九百、老百姓等涨停，达嘉维康、*ST人乐、开开实业、茂业商业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2466900911","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466900911?lang=zh_cn&edition=full","pubTime":"2024-09-09 10:24","pubTimestamp":1725848696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0099","BK0077","BK0184","600272","600838","603883","BK0189","002336","BK0209","600828","301126","BK0250","BK0170","BK0188"],"gpt_icon":0},{"id":"2465956375","title":"A股医药商业概念持续活跃，老百姓5天4板，漱玉平民、人民同泰、达嘉维康、浙江震元等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2465956375","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465956375?lang=zh_cn&edition=full","pubTime":"2024-09-05 09:27","pubTimestamp":1725499657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","BK1574","301017","603883","09939","BK1161","BK1515","000705","BK0209","301126","BK0250","159982","159938","600829"],"gpt_icon":0},{"id":"2464809104","title":"达嘉维康：国金证券、西部证券等多家机构于9月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2464809104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464809104?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:14","pubTimestamp":1725369279,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月3日达嘉维康发布公告称国金证券袁维 王奔奔、西部证券李梦园 邓琳茜、国盛证券张金洋 胡偌碧 张玉、海通证券余文心 周航 张澄 孙旭东、方正证券周超泽 窦慧敏 郭雪寒于2024年9月3日调研我司。截至2024年6月30日，公司在全国共计开设药房1,104家，其中直营门店989家，加盟门店115家，目前主要以直营连锁为主，门店已覆盖湖南、海南、宁夏、山西、北京、甘肃等地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300036988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0201","BK0250","BK0188","301126","002673","BK0183","BK0012","600109","BK0028"],"gpt_icon":0},{"id":"2464882871","title":"联邦制药与达嘉维康举行合作交流座谈会","url":"https://stock-news.laohu8.com/highlight/detail?id=2464882871","media":"联邦制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464882871?lang=zh_cn&edition=full","pubTime":"2024-09-03 15:12","pubTimestamp":1725347568,"startTime":"0","endTime":"0","summary":"9月2日，联邦制药与达嘉维康在联邦制药珠海公司举行了合作交流座谈会。达嘉维康董事长王毅清一行受到联邦制药董事局主席蔡海山及高层管理团队的热情接待。座谈会上，蔡海山主席对王毅清董事 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20240903/c661389009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0250","301126"],"gpt_icon":0},{"id":"2464837648","title":"达嘉维康最新公告：股东拟减持不超过3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2464837648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464837648?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:39","pubTimestamp":1725284376,"startTime":"0","endTime":"0","summary":"达嘉维康公告，特定股东量吉投资及其一致行动人淳康投资计划减持公司股份数量合计不超过616.21万股（占公司总股本的3.00%）。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200033292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301126","BK0250"],"gpt_icon":0},{"id":"2464837815","title":"达嘉维康(301126.SZ)股东量吉投资及其一致行动人淳康投资拟合计减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464837815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464837815?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:38","pubTimestamp":1725284303,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达嘉维康(301126.SZ)公告，公司收到股东量吉投资及其一致行动人淳康投资出具的《关于股份减持计划的告知函》，特定股东宁波梅山保税港区量吉股权投资合伙企业(有限合伙)(简称“量吉投资”)及其一致行动人宁波梅山保税港区淳康股权投资合伙企业(有限合伙)(简称“淳康投资”)计划自本公告披露之日起3个交易日后的3个月内以集中竞价或大宗交易方式减持公司股份数量合计不超过616.21万股(占公司总股本的3.00%)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301126","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-12-07","address":"湖南省长沙市岳麓区茯苓路30号","stockEarnings":[{"period":"1week","weight":-0.0761},{"period":"1month","weight":-0.0284},{"period":"3month","weight":0.2859},{"period":"6month","weight":0.2643},{"period":"1year","weight":-0.1307},{"period":"ytd","weight":-0.13}],"companyName":"湖南达嘉维康医药产业股份有限公司","boardCode":"AI0051","perCapita":"8770股","boardName":"批发业","registeredCapital":"20540万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 湖南达嘉维康医药产业股份有限公司主要从事药品、生物制品、医疗器械等产品的分销及零售业务。公司主要服务包括分销业务、“特门服务”药房业务、DTP业务、生殖医院业务以及药房传统业务。公司凭借专业药房的规范化管理，2019年通过《零售药店经营特殊疾病药品服务规范》（“特药药房标准”），成为全国第一批达标药店，并荣获“2019年度十大DTP药房”、“2019年中国药品零售最具竞争力优秀门店”、“2019年度全国百家优秀民营医药商业流通企业”、“2020年优秀DTP专业药房”。","serverTime":1734717797806,"listedPrice":12.37,"stockholders":"15721人(较上一季度增加0.68%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达嘉维康,301126,达嘉维康股票,达嘉维康股票老虎,达嘉维康股票老虎国际,达嘉维康行情,达嘉维康股票行情,达嘉维康股价,达嘉维康股市,达嘉维康股票价格,达嘉维康股票交易,达嘉维康股票购买,达嘉维康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达嘉维康(301126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达嘉维康(301126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}